Latest Breaking News On - European commission approved ebola - Page 1 : comparemela.com

Search jobs Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine NEW BRUNSWICK, N.J., April 21, 2021 – Johnson & Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson & Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participants 28 days after vaccination.

United statesSouth africaSouth africanPaul stoffelsMathai mammenPharmacovigilance risk assessment committeeUs centers for diseaseNational institute of allergyJanssen research developmentEuropean unionEuropean commission onJanssen pharmaceutical companies of johnsonUs department of healthBiomedical advanced researchNational institutes of healthHuman services